Abstract
Transcription factors of the NF-κB family are essential regulators of the inflammatory and immune responses. The main 'switch' in NF-κB activation is cytoplasmic and leads to the release of NF-κB proteins from IκB molecules, specific inhibitors that prevent their nuclear accumulation. However, it is becoming increasingly apparent that in addition to this required activation step, both recruitment of NF-κB to target genes and NF-κB-induced transcriptional events after recruitment are actively controlled. Regulated recruitment of NF-κB to chromatin generates kinetic complexity in NF-κB-dependent gene induction and 'wires' NF-κB-regulated gene activity to simultaneously activated pathways and transcription factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D. & Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9, 2723–2735 (1995).
Baldwin, A.S., Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649–683 (1996).
Ghosh, S., May, M.J. & Kopp, E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260 (1998).
Liou, H.C., Sha, W.C., Scott, M.L. & Baltimore, D. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14, 5349–5359 (1994).
Saccani, S., Pantano, S. & Natoli, G. Modulation of NF-κB activity by exchange of dimers. Mol. Cell 11, 1563–1574 (2003).
Grilli, M., Chiu, J.J. & Lenardo, M.J. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1–62 (1993).
Verweij, C.L., Geerts, M. & Aarden, L.A. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266, 14179–14182 (1991).
Huang, D.B., Chen, Y.Q., Ruetsche, M., Phelps, C.B. & Ghosh, G. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure (Camb.) 9, 669–678 (2001).
Hansen, S.K., Guerrini, L. & Blasi, F. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. J. Biol. Chem. 269, 22230–22237 (1994).
Martone, R. et al. Distribution of NF-κB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 100, 12247–12252 (2003).
Hottiger, M.O., Felzien, L.K. & Nabel, G.J. Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J. 17, 3124–3134 (1998).
Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499–509 (2004).
Fernandez, P.C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115–1129 (2003).
Udalova, I.A., Mott, R., Field, D. & Kwiatkowski, D. Quantitative prediction of NF-κB DNA-protein interactions. Proc. Natl. Acad. Sci. USA 99, 8167–8172 (2002).
Hoffmann, A., Leung, T.H. & Baltimore, D. Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22, 5530–5539 (2003).
Lin, R., Gewert, D. & Hiscott, J. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270, 3123–3131 (1995).
Algarte, M., Kwon, H., Genin, P. & Hiscott, J. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-κB and Sp1 that regulates the IκBα promoter. Mol. Cell. Biol. 19, 6140–6153 (1999).
Bonizzi, G. et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23, 4202–4210 (2004).
Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).
Govind, S. Control of development and immunity by rel transcription factors in Drosophila. Oncogene 18, 6875–6887 (1999).
Jiang, J. & Levine, M. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72, 741–752 (1993).
Leung, T.H., Hoffmann, A. & Baltimore, D. One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers. Cell 118, 453–464 (2004).
Natoli, G. Little things that count in transcriptional regulation. Cell 118, 406–408 (2004).
Walker, S., Hayes, S. & O'Hare, P. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79, 841–852 (1994).
Lefstin, J.A. & Yamamoto, K.R. Allosteric effects of DNA on transcriptional regulators. Nature 392, 885–888 (1998).
Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218–222 (2004).
Urban, M.B. & Baeuerle, P.A. The 65-kD subunit of NF-κB is a receptor for I κB and a modulator of DNA-binding specificity. Genes Dev. 4, 1975–1984 (1990).
Thanos, D. & Maniatis, T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83, 1091–1100 (1995).
Chen-Park, F.E., Huang, D.B., Noro, B., Thanos, D. & Ghosh, G. The κB DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J. Biol. Chem. 277, 24701–24708 (2002).
Saccani, S., Pantano, S. & Natoli, G. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193, 1351–1359 (2001).
Saccani, S., Marazzi, I., Beg, A.A. & Natoli, G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J. Exp. Med. 200, 107–113 (2004).
Saccani, S., Pantano, S. & Natoli, G. p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3, 69–75 (2002).
Chen, D. et al. Regulation of transcription by a protein methyltransferase. Science 284, 2174–2177 (1999).
Covic, M. et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression. EMBO J. 24, 85–96 (2005).
Haller, D. et al. Transforming growth factor-β 1 inhibits non-pathogenic Gram negative bacteria-induced NF-κB recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J. Biol. Chem. 278, 23851–23860 (2003).
Phelps, C.B., Sengchanthalangsy, L.L., Malek, S. & Ghosh, G. Mechanism of κB DNA binding by Rel/NF-κB dimers. J. Biol. Chem. 275, 24392–24399 (2000).
Munshi, N. et al. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293, 1133–1136 (2001).
Genin, P., Algarte, M., Roof, P., Lin, R. & Hiscott, J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription factors. J. Immunol. 164, 5352–5361 (2000).
Guo, Z., Boekhoudt, G.H. & Boss, J.M. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J. Biol. Chem. 278, 23570–23578 (2003).
Boekhoudt, G.H., Guo, Z., Beresford, G.W. & Boss, J.M. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 170, 4139–4147 (2003).
Kornberg, R.D. & Lorch, Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285–294 (1999).
Imbalzano, A.N., Kwon, H., Green, M.R. & Kingston, R.E. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature 370, 481–485 (1994).
Taylor, I.C., Workman, J.L., Schuetz, T.J. & Kingston, R.E. Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: differential function of DNA-binding domains. Genes Dev. 5, 1285–1298 (1991).
Li, B., Adams, C.C. & Workman, J.L. Nucleosome binding by the constitutive transcription factor Sp1. J. Biol. Chem. 269, 7756–7763 (1994).
Perlmann, T. & Wrange, O. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7, 3073–3079 (1988).
Anderson, J.D. & Widom, J. Sequence and position-dependence of the equilibrium accessibility of nucleosomal DNA target sites. J. Mol. Biol. 296, 979–987 (2000).
Polach, K.J. & Widom, J. Mechanism of protein access to specific DNA sequences in chromatin: a dynamic equilibrium model for gene regulation. J. Mol. Biol. 254, 130–149 (1995).
Widom, J. Structure, dynamics, and function of chromatin in vitro. Annu. Rev. Biophys. Biomol. Struct. 27, 285–327 (1998).
Li, Q. & Wrange, O. Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol. Cell. Biol. 15, 4375–4384 (1995).
Ghosh, G., van Duyne, G., Ghosh, S. & Sigler, P.B. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373, 303–310 (1995).
Muller, C.W., Rey, F.A., Sodeoka, M., Verdine, G.L. & Harrison, S.C. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373, 311–317 (1995).
Chen, F.E., Huang, D.B., Chen, Y.Q. & Ghosh, G. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391, 410–413 (1998).
Huxford, T., Malek, S. & Ghosh, G. Structure and mechanism in NF-κB/IκB signaling. Cold Spring Harb. Symp. Quant. Biol. 64, 533–540 (1999).
Angelov, D. et al. The histone octamer is invisible when NF-κB binds to the nucleosome. J. Biol. Chem. 279, 42374–42382 (2004).
Steger, D.J. & Workman, J.L. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J. 16, 2463–2472 (1997).
Holloway, A.F., Rao, S., Chen, X. & Shannon, M.F. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor κB proteins. J. Exp. Med. 197, 413–423 (2003).
Weinmann, A.S., Plevy, S.E. & Smale, S.T. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 11, 665–675 (1999).
Agalioti, T. et al. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter. Cell 103, 667–678 (2000).
Lomvardas, S. & Thanos, D. Nucleosome sliding via TBP DNA binding in vivo. Cell 106, 685–696 (2001).
Angelov, D. et al. The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol. Cell 11, 1033–1041 (2003).
Perche, P.Y. et al. Higher concentrations of histone macroH2A in the Barr body are correlated with higher nucleosome density. Curr. Biol. 10, 1531–1534 (2000).
De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488–522 (2003).
Nissen, R.M. & Yamamoto, K.R. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314–2329 (2000).
Price, D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20, 2629–2634 (2000).
Kassel, O. et al. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev. 18, 2518–2528 (2004).
Barboric, M., Nissen, R.M., Kanazawa, S., Jabrane-Ferrat, N. & Peterlin, B.M. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8, 327–337 (2001).
Zhong, H., May, M.J., Jimi, E. & Ghosh, S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625–636 (2002).
Duran, A., Diaz-Meco, M.T. & Moscat, J. Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcriptional activation. EMBO J. 22, 3910–3918 (2003).
Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W. & Haegeman, G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22, 1313–1324 (2003).
Anest, V. et al. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659–663 (2003).
Yamamoto, Y., Verma, U.N., Prajapati, S., Kwak, Y.T. & Gaynor, R.B. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655–659 (2003).
Hoberg, J.E., Yeung, F. & Mayo, M.W. SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol. Cell 16, 245–255 (2004).
Chen, L.F. & Greene, W.C. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5, 392–401 (2004).
Yamamoto, Y. & Gaynor, R.B. IκB kinases: key regulators of the NF-κB pathway. Trends Biochem. Sci. 29, 72–79 (2004).
Zabel, U. & Baeuerle, P.A. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61, 255–265 (1990).
Arenzana-Seisdedos, F. et al. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689–2696 (1995).
Beg, A.A., Sha, W.C., Bronson, R.T. & Baltimore, D. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9, 2736–2746 (1995).
Arenzana-Seisdedos, F. et al. Nuclear localization of IκB alpha promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110, 369–378 (1997).
Kung, A.L. et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6, 33–43 (2004).
Lepourcelet, M. et al. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 5, 91–102 (2004).
Lenhard, B. et al. Identification of conserved regulatory elements by comparative genome analysis. J. Biol. 2, 13 (2003).
Kunsch, C., Ruben, S.M. & Rosen, C.A. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12, 4412–4421 (1992).
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F. & Richmond, T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251–260 (1997).
Acknowledgements
We thank S. Dimitrov (Institute Albert Bonniot, Grenoble, Switzerland) and M.E. Bianchi (Dipartimento Biotecnologie, San Raffaele Institute, Milan, Italy) for discussions and insights; and W. Vandenberghe and G. Haegeman (University of Gent, Gent, Belgium) for suggestions on the manuscript. Supported by the Swiss National Science Foundation and Swiss League against Cancer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Natoli, G., Saccani, S., Bosisio, D. et al. Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nat Immunol 6, 439–445 (2005). https://doi.org/10.1038/ni1196
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1196
This article is cited by
-
DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway
Cellular and Molecular Life Sciences (2021)
-
HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6
Cell Death & Disease (2020)
-
Cholesterol restricts lymphotoxin β receptor-triggered NF-κB signaling
Cell Communication and Signaling (2019)
-
Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes
Scientific Reports (2016)
-
The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
Scientific Reports (2016)